RT Journal Article
T1 Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism.
T2 Consenso multidisciplinar para el manejo de la tromboembolia de pulmón.
A1 Lobo, José Luis
A1 Alonso, Sergio
A1 Arenas, Juan
A1 Domènech, Pere
A1 Escribano, Pilar
A1 Fernández-Capitán, Carmen
A1 Jara-Palomares, Luis
A1 Jiménez, Sonia
A1 Lázaro, María
A1 Lecumberri, Ramón
A1 Monreal, Manuel
A1 Ruiz-Artacho, Pedro
A1 Jiménez, David
A1 en nombre del Panel Multidisciplinar para el Manejo de la TEP, 
K1 Diagnosis
K1 Diagnóstico
K1 Prognosis
K1 Pronóstico
K1 Pulmonary embolism
K1 Tratamiento
K1 Treatment
K1 Tromboembolia de pulmón
AB We have updated recommendations on 12 controversial topics that were published in the 2013 National Consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism (PE). A comprehensive review of the literature was performed for each topic, and each recommendation was evaluated in two teleconferences. For diagnosis, we recommend against using the Pulmonary Embolism Rule Out Criteria (PERC) rule as the only test to rule out PE, and we recommend using a D-dimer cutoff adjusted to age to rule out PE. We suggest using computed tomography pulmonary angiogram as the imaging test of choice for the majority of patients with suspected PE. We recommend using direct oral anticoagulants (over vitamin K antagonists) for the vast majority of patients with acute PE, and we suggest using anticoagulation for patients with isolated subsegmental PE. We recommend against inserting an inferior cava filter for the majority of patients with PE, and we recommend using full-dose systemic thrombolytic therapy for PE patients requiring reperfusion. The decision to stop anticoagulants at 3 months or to treat indefinitely mainly depends on the presence (or absence) and type of risk factor for venous thromboembolism, and we recommend against thrombophilia testing to decide duration of anticoagulation. Finally, we suggest against extensive screening for occult cancer in patients with PE.
YR 2021
FD 2021-02-13
LK http://hdl.handle.net/10668/21980
UL http://hdl.handle.net/10668/21980
LA en
LA es
DS RISalud
RD Apr 12, 2025